| Joann Vu Adams, OD | |
|
7075 N Sharon Ave, Fresno, CA 93720-3329 | |
| (559) 486-2000 | |
| (559) 256-8595 |
| Full Name | Joann Vu Adams |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 6 Years |
| Location | 7075 N Sharon Ave, Fresno, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124688189 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 2019018013 (Missouri) | Secondary |
| 152W00000X | Optometrist | 34849 (California) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Vision Care Center A Medical Group Inc | 8729985015 | 20 |
News Archive
Researchers have recently identified two nanobodies that show specific binding against a SARS-CoV-2 replication protein.
Stem cells from patients with a rare form of muscular dystrophy have been successfully transplanted into mice affected by the same form of dystrophy, according to a new study published today in Science Translational Medicine.
Commonwealth Biotechnologies, Inc. ("CBI" or "Company")) (NASDAQ Capital Market:CBTE) today announced that on September 15, 2009, CBI received a letter from The NASDAQ Stock Market indicating that the bid price of the Company's common stock had closed below the minimum $1.00 per share threshold set forth in NASDAQ Listing Rule 5550(a)(2) for the prior 30 consecutive business days.
The most detailed analysis yet of the role germline mutations in genes associated with cancer predisposition play in the development of childhood cancer suggests that comprehensive genomic screening may be warranted on all pediatric cancer patients, not just those with a family history of cancer.
› Verified 4 days ago
| Provider Name | Vision Care Center A Medical Group Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1194802868 PECOS PAC ID: 8729985015 Enrollment ID: O20031215000954 |
News Archive
Researchers have recently identified two nanobodies that show specific binding against a SARS-CoV-2 replication protein.
Stem cells from patients with a rare form of muscular dystrophy have been successfully transplanted into mice affected by the same form of dystrophy, according to a new study published today in Science Translational Medicine.
Commonwealth Biotechnologies, Inc. ("CBI" or "Company")) (NASDAQ Capital Market:CBTE) today announced that on September 15, 2009, CBI received a letter from The NASDAQ Stock Market indicating that the bid price of the Company's common stock had closed below the minimum $1.00 per share threshold set forth in NASDAQ Listing Rule 5550(a)(2) for the prior 30 consecutive business days.
The most detailed analysis yet of the role germline mutations in genes associated with cancer predisposition play in the development of childhood cancer suggests that comprehensive genomic screening may be warranted on all pediatric cancer patients, not just those with a family history of cancer.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joann Vu Adams, OD 7075 N Sharon Ave, Fresno, CA 93720-3329 Ph: (559) 486-2000 | Joann Vu Adams, OD 7075 N Sharon Ave, Fresno, CA 93720-3329 Ph: (559) 486-2000 |
News Archive
Researchers have recently identified two nanobodies that show specific binding against a SARS-CoV-2 replication protein.
Stem cells from patients with a rare form of muscular dystrophy have been successfully transplanted into mice affected by the same form of dystrophy, according to a new study published today in Science Translational Medicine.
Commonwealth Biotechnologies, Inc. ("CBI" or "Company")) (NASDAQ Capital Market:CBTE) today announced that on September 15, 2009, CBI received a letter from The NASDAQ Stock Market indicating that the bid price of the Company's common stock had closed below the minimum $1.00 per share threshold set forth in NASDAQ Listing Rule 5550(a)(2) for the prior 30 consecutive business days.
The most detailed analysis yet of the role germline mutations in genes associated with cancer predisposition play in the development of childhood cancer suggests that comprehensive genomic screening may be warranted on all pediatric cancer patients, not just those with a family history of cancer.
› Verified 4 days ago
Dr. Scott Randall Hultman, O,D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3636 N Blackstone Ave, Fresno, CA 93726 Phone: 559-244-3319 | |
Dr. Thomas Pearson, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 1360 E Herndon Ave, Suite 401, Fresno, CA 93720 Phone: 559-449-5010 Fax: 559-449-5014 | |
Eye-q Vision Care Optometrist Medicare: Not Enrolled in Medicare Practice Location: 7075 N Sharon Ave, Fresno, CA 93720 Phone: 559-486-2000 | |
Dr. Andrea Cristina Huerta, OD Optometrist Medicare: Medicare Enrolled Practice Location: 7075 N Sharon Ave, Fresno, CA 93720 Phone: 559-389-5723 Fax: 559-256-8595 | |
Dr. David R Urien, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 5430 N Palm Ave, Suite 101, Fresno, CA 93704 Phone: 559-432-0606 Fax: 559-432-0608 | |
Dr. Steven W. Shute, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 7075 N Sharon Ave, Fresno, CA 93720 Phone: 559-486-2000 | |
Dr. Elmer Wong, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 6700 N 1st St, 103, Fresno, CA 93710 Phone: 559-438-6440 Fax: 559-438-4324 |